BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Catalyst Pharmaceutical Partners, Inc. 

355 Alhambra Circle, Suite 1500

Coral Gables  Florida  33134  U.S.A.
Phone: 305-529-2522 Fax: 305-529-0933


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Catalyst Pharmaceuticals (CPRX) Announces Notice Of Allowance Of U.S. Patent Application For The Reduction Or Elimination Of Visual Field Defects By Treating Patients With CPP-115 11/24/2014 1:13:45 PM
Catalyst Pharmaceuticals (CPRX) CEO Outlines Biotech's 5 Phases Of Risk 11/24/2014 4:28:54 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Third Quarter 2014 Financial Results 11/14/2014 7:53:13 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Proposed Settlement Of Pending Securities Class Action Lawsuit 11/4/2014 7:25:32 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Appoints David J. Caponera As Vice President Patient Advocacy And Reimbursement 10/28/2014 7:13:30 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) To Present Firdapse Phase 3 Trial Results At The 61st Annual Meeting Of The American Association Of Neuromuscular And Electrodiagnostic Medicine 10/27/2014 7:33:40 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) To Present Top-Line Safety And Efficacy Results From Phase 3 Firdapse Trial At 139th Annual Meeting Of The American Neurological Association 10/8/2014 7:19:36 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Will Hire 25 Staffers After Successful Drug Trial 10/7/2014 6:26:26 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Positive Top-Line Phase 3 Data From Pivotal Firdapse Clinical Trial In Patients With Lambert-Eaton Myasthenic Syndrome (LEMS) 9/29/2014 1:12:57 PM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Appoints David D. Muth As Executive Vice President, Corporate Development 9/4/2014 8:51:00 AM
12345678910...